SCORIC-A: Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05613712
Collaborator
(none)
400
1
3.9
102.3

Study Details

Study Description

Brief Summary

Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Condition or Disease Intervention/Treatment Phase
  • Other: Patients
  • Other: Referring physician

Detailed Description

In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients

Patients followed by the rheumatology department of the CHU Grenoble Alpes, constituting the SCORIC group

Other: Patients
Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up

Referring physician

Physicians identified as the referring physician for patients in the SCORIC group

Other: Referring physician
Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes

Outcome Measures

Primary Outcome Measures

  1. Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires [1 day]

    Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Secondary Outcome Measures

  1. Elements limiting the good ambulatory follow-up, according to the patients [1 day]

    Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up

  2. Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients [1 day]

    Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient cohort :

  • men and women over 18 years of age

  • Informed volunteers who have consented to participate in the study

  • have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis

  • have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department

  • Cohort of referring physicians :

  • volunteers who received informed information and consented to participate in the study

  • be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes

Exclusion Criteria:
  • Patient cohort :

  • psychiatric pathologies or history of behavioural disorders

  • persons referred to in articles L1121-5 to L1121-8 of the Public Health Code

  • persons under guardianship or curatorship

  • not affiliated to the social security system

  • minors

  • Refusal to participate by the patient and/or unreturned questionnaire

  • Cohort of referring physicians:

  • the physician is no longer the patient's referring physician

  • refusal of the doctor to participate and/or questionnaire not returned

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Grenoble Alpes Grenoble France 38043

Sponsors and Collaborators

  • University Hospital, Grenoble

Investigators

  • Principal Investigator: Xavier ROMAND, PHD, CHU Grenoble Alpes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT05613712
Other Study ID Numbers:
  • 38RC22.0355
First Posted:
Nov 14, 2022
Last Update Posted:
Dec 23, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Grenoble
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2022